Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Leukemia

Free Subscription 04.08.2025 3 Acta Haematol 1 Am J Clin Pathol 4 Ann Hematol 3 Blood 1 BMC Cancer 1 Eur J Haematol 1 Exp Hematol 1 Gene 1 Hematol Oncol Clin North Am 1 Int J Hematol 1 J Clin Oncol 3 Leuk Lymphoma 1 Leuk Res 6 Leukemia 1 Oncol Rep 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acta Haematol

1. SENAPATI J, Short NJ
   Advances in Acute Lymphoblastic Leukemia Review Series.
   Acta Haematol. 2025 Jul 29:1-5. doi: 10.1159/000547659.
   PubMed        
   
   
2. RAFAELI N, Kebriaei P
   Future Directions in Allogeneic Stem Cell Transplantation in Acute Lymphoblastic Leukemia.
   Acta Haematol. 2025 Jul 25:1-12. doi: 10.1159/000547644.
   PubMed         Abstract available
   
   
3. SANCHEZ-PETITTO G, Goloubeva O, Childress J, Iqbal T, et al
   Outcomes of Patients with Myeloid Malignancies and Cardiovascular Disease Undergoing Allogeneic Stem Cell Transplantation.
   Acta Haematol. 2025;148:386-397.
   PubMed         Abstract available
   
   

   
   Am J Clin Pathol

4. SABATINI P, Zhang T, Boruvka N, Kim HS, et al
   Methylation-based droplet digital polymerase chain reaction shows high concordance with chronic lymphocytic leukemia IGHV somatic mutation status.
   Am J Clin Pathol. 2025 Jul 30:aqaf075. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Ann Hematol

5. PARK H, Kim HJ, Sohn SK, Baik Y, et al
   Gene expression analysis of patients with chronic myeloid leukemia who discontinued tyrosine kinase inhibitor.
   Ann Hematol. 2025 Jul 31. doi: 10.1007/s00277-025-06514.
   PubMed         Abstract available
   
   
6. LAZAR DR, Maniu D, Lazar FL, Blag C, et al
   Exploring the baseline cardiac function and its correlation with risk stratification in children diagnosed with acute lymphoblastic leukemia.
   Ann Hematol. 2025 Jul 30. doi: 10.1007/s00277-025-06523.
   PubMed         Abstract available
   
   
7. QUINQUENEL A, Lepretre S, Dilhuydy MS, Bussot L, et al
   Real-world efficacy and safety outcomes of acalabrutinib in chronic lymphocytic leukemia: primary results of a French multicentre observational study (NAOS).
   Ann Hematol. 2025 Jul 30. doi: 10.1007/s00277-025-06498.
   PubMed         Abstract available
   
   
8. HUANG L, Shi X, Tang N, Liu J, et al
   Prognostic significance of in patients with chronic lymphocytic leukemia: A meta-analysis.
   Ann Hematol. 2025 Jul 30. doi: 10.1007/s00277-025-06499.
   PubMed         Abstract available
   
   

   
   Blood

9. PAULI C, Kienhofer M, Blank MF, Begik O, et al
   Disrupting tRNA modifications to target mitochondrial vulnerabilities in drug-resistant leukemia cells.
   Blood. 2025 Aug 1:blood.2024027822. doi: 10.1182/blood.2024027822.
   PubMed         Abstract available
   
   
10. SMITH A, Denny NDR, Chahrour C, Sharp K, et al
    Enhancer heterogeneity in acute lymphoblastic leukemia drives differential gene expression in patients.
    Blood. 2025 Jul 29:blood.2024028019. doi: 10.1182/blood.2024028019.
    PubMed         Abstract available
    
    
11. DAVER N, Vyas P, Huls G, Dohner H, et al
    The ENHANCE-3 study: venetoclax and azacitidine plus magrolimab or placebo for untreated AML unfit for intensive therapy.
    Blood. 2025;146:601-611.
    PubMed         Abstract available
    
    

    
    BMC Cancer

12. JIANG S, Ma L, Huang T, Wang T, et al
    Azelaic acid attenuates CCL2/CCR2 axis-mediated skin trafficking of acute myeloid leukemia cells through NF-kappaB/MAPK signaling modulation in keratinocytes.
    BMC Cancer. 2025;25:1250.
    PubMed         Abstract available
    
    

    
    Eur J Haematol

13. MAHAMEED B, Sharf G, Tadmor T, Kleinstern G, et al
    Gender Disparities in Health-Related Quality of Life in Patients With Chronic Lymphocytic Leukemia: Impact of Treatment Modality.
    Eur J Haematol. 2025 Jul 31. doi: 10.1111/ejh.70017.
    PubMed         Abstract available
    
    

    
    Exp Hematol

14. SAMAREH B, Klimenkova O, Aghaallaei N, Cheng L, et al
    NAMPT-mediated deacetylation of HCLS1 protein promotes clonogenic growth of pediatric CML cells.
    Exp Hematol. 2025;148:104801.
    PubMed         Abstract available
    
    

    
    Gene

15. YU H, Yan L
    Mitochondrial metabolism: Critical mechanisms underpinning normal hematopoietic stem cell and acute myeloid leukemia stem cell function.
    Gene. 2025;966:149685.
    PubMed         Abstract available
    
    

    
    Hematol Oncol Clin North Am

16. VAINER N, Katsimigas A, Rotbain EC, Niemann CU, et al
    Understanding and Managing Infectious Complications in Chronic Lymphocytic Leukemia.
    Hematol Oncol Clin North Am. 2025 Jul 25:S0889-8588(25)00065.
    PubMed         Abstract available
    
    

    
    Int J Hematol

17. LIU ZY, Yan ZY, Li JF, Zhu YM, et al
    Differences in response to immunotherapy drugs including blinatumomab and inotuzumab ozogamicin in B-ALL patients.
    Int J Hematol. 2025;122:295-300.
    PubMed         Abstract available
    
    

    
    J Clin Oncol

18. SHARMAN JP, Munir T, Grosicki S, Roeker LE, et al
    Erratum: Phase III Trial of Pirtobrutinib Versus Idelalisib/Rituximab or Bendamustine/Rituximab in Covalent Bruton Tyrosine Kinase Inhibitor-Pretreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BRUIN CLL-321).
    J Clin Oncol. 2025 Jul 29:JCO2501700. doi: 10.1200/JCO-25-01700.
    PubMed        
    
    

    
    Leuk Lymphoma

19. LU L, Liang J, Wang L, Chen Z, et al
    Venetoclax promotes acute myeloid leukemia cells apoptosis by decreasing ac4C modification and mRNA expression of IMP3 through downregulating NAT10.
    Leuk Lymphoma. 2025 Jul 31:1-11. doi: 10.1080/10428194.2025.2540445.
    PubMed         Abstract available
    
    
20. PODGORICA M, Drivet E, Vestbostad J, Kvam AK, et al
    Azaindole 1, a selective Rock1/2 kinase inhibitor, induces G2/M arrest and cell death in B-cell acute lymphoblastic leukemia (B-ALL).
    Leuk Lymphoma. 2025 Jul 29:1-5. doi: 10.1080/10428194.2025.2536125.
    PubMed        
    
    
21. MULLIGAN SP, Thompson PA, Wight J, Anderson MA, et al
    Real-world utilization of Bruton tyrosine kinase inhibitors in relapsed/refractory chronic lymphocytic leukemia in Australia.
    Leuk Lymphoma. 2025 Jul 27:1-11. doi: 10.1080/10428194.2025.2533498.
    PubMed         Abstract available
    
    

    
    Leuk Res

22. MUDD TW, Diebold K, Parks K, Hardee M, et al
    Outcomes with intensive chemotherapy, compared to hypomethylating agent + venetoclax, in patients with intermediate and adverse risk acute myeloid leukemia.
    Leuk Res. 2025;156:107920.
    PubMed        
    
    

    
    Leukemia

23. CALABRETTO G, Binatti A, Teramo A, Buratin A, et al
    Transcriptomic landscape of CD8+ and CD4 + T-LGL leukemia revealed the distinct impact of STAT3 and STAT5B activating mutations.
    Leukemia. 2025 Jul 28. doi: 10.1038/s41375-025-02708.
    PubMed         Abstract available
    
    
24. LIEBER MR, Hsieh CL
    On the mechanism of NPM1 mutations in acute myeloid leukemia.
    Leukemia. 2025 Jul 28. doi: 10.1038/s41375-025-02722.
    PubMed        
    
    
25. EHRMANN AS, Quijada-Alamo M, Close V, Guo M, et al
    NOTCH1 signaling is dysregulated by loss of the deubiquitinase USP28 with del(11q), uncovering USP28 inhibition as novel therapeutic target in CLL.
    Leukemia. 2025;39:1892-1904.
    PubMed         Abstract available
    
    
26. YAN J, Shi C, Yang G, Tian Z, et al
    T cell receptor mimic CAR T cells targeting cathepsin G signal peptide.
    Leukemia. 2025;39:1948-1959.
    PubMed         Abstract available
    
    
27. BERG V, Lollies A, Schneider M, Johansson P, et al
    Common origin and somatic mutation patterns of composite lymphomas and leukemias.
    Leukemia. 2025;39:1960-1971.
    PubMed         Abstract available
    
    
28. ZOU J, Kinosada H, Takayanagi SI, Ishii T, et al
    KK2845, a PBD dimer-containing antibody-drug conjugate targeting TIM-3-expressing AML.
    Leukemia. 2025;39:1848-1856.
    PubMed         Abstract available
    
    

    
    Oncol Rep

29. YU Y, Duan S, He J, Liang W, et al
    [Corrigendum] Highly sensitive detection of leukemia cells based on aptamer and quantum dots.
    Oncol Rep. 2025;54:129.
    PubMed         Abstract available
    
    

    
    PLoS One

30. AHMADI A, Navidinia AA, Bashash D, Poopak B, et al
    Derivation of a novel multi-gene prognostic model based on regulated cell death pathways in acute myeloid leukemia: A comprehensive bioinformatic analysis integrating gene expression, mutation profiling, and immune infiltration.
    PLoS One. 2025;20:e0328412.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge.